abnormal estrus, abnormal excitatory postsynaptic currents, abnormal hormone level, abnormal inhibitory postsynaptic currents, abnormal intestinal absorption, abnormal intestinal transit time, abnormal large intestinal transit time, abnormal latent inhibition of conditioning behavior, abnormal locomotor activation, abnormal locomotor behavior, abnormal melanotroph morphology, abnormal neuron physiology, abnormal operant conditioning behavior, abnormal pituitary gland physiology, abnormal prepulse inhibition, abnormal response to novel odor, abnormal single cell response, abnormal synaptic dopamine release, abnormal systemic arterial blood pressure, abnormal vocalization, absent long term depression, adenohypophysis hyperplasia, adenohypophysis hypertrophy, adenohypophysis peliosis, adrenal cortical hyperplasia, alcohol aversion, behavior/neurological phenotype, catalepsy, darkened coat color, decreased aggression towards male mice, decreased alcohol consumption, decreased anxiety-related response, decreased body length, decreased body size, decreased circulating estrogen level, decreased circulating growth hormone level, decreased circulating insulin-like growth factor I level, decreased dopaminergic neuron number, decreased fluid intake, decreased food intake, decreased gonadotroph cell number, decreased growth hormone level, decreased inguinal fat pad weight, decreased lactotroph cell size, decreased liver weight, decreased locomotor activity, decreased physiological sensitivity to xenobiotic, decreased pulmonary ventilation, decreased response to stress-induced hyperthermia, decreased sensitivity to xenobiotic induced morbidity/mortality, decreased somatotroph cell number, decreased spleen weight, decreased startle reflex, decreased urine major urinary protein level, decreased vertical activity, enhanced behavioral response to anesthetic, enhanced behavioral response to cocaine, enhanced behavioral response to xenobiotic, enlarged adrenocortical cells, enlarged pituitary intermediate lobe, growth/size/body region phenotype, homeostasis/metabolism phenotype, hunched posture, hyperpigmentation, hypersecretion of corticosterone, impaired behavioral response to addictive substance, impaired behavioral response to alcohol, impaired behavioral response to anesthetic, impaired behavioral response to cocaine, impaired behavioral response to xenobiotic, impaired conditioned place preference behavior, increased circulating pituitary hormone level, increased circulating prolactin level, increased defecation amount, increased dopamine level, increased fluid intake, increased food intake, increased growth hormone level, increased interleukin-1 beta secretion, increased lactotroph cell number, increased mean systemic arterial blood pressure, increased physiological sensitivity to xenobiotic, increased pituitary adenoma incidence, increased pituitary gland weight, increased pituitary hormone level, increased pulmonary respiratory rate, increased pulmonary ventilation, increased susceptibility to dopaminergic neuron neurotoxicity, increased susceptibility to neuronal excitotoxicity, increased susceptibility to pharmacologically induced seizures, increased systemic arterial diastolic blood pressure, increased systemic arterial systolic blood pressure, increased thyrotroph cell number, increased tidal volume, increased urine sodium level, increased vertical activity, induced hyperactivity, limp posture, microgliosis, nervous system phenotype, no abnormal phenotype detected, pituitary gland hyperplasia, pituitary intermediate lobe hyperplasia, premature death, prolonged diestrus, reduced female fertility, reduced fertility, short uterine horn, slow postnatal weight gain, small ovary, taste/olfaction phenotype, unidirectional circling, uterus adenomyosis, uterus cyst, uterus hyperplasia